Literature DB >> 28883881

Zinc and Copper Metabolism and Risk of Autism: a reply to Sayehmiri et al.

Keith Fluegge Ba1.   

Abstract

OBJECTIVE: Sayehmiri et al. recently conducted a meta-analysis to explore the relationship between zinc and copper metabolism and autism spectrum disorders (ASD). Recent reports have elucidated a full behavioral profile of mice exposed to prenatal zinc deficiency and documented a phenotype similar to that found in autism spectrum disorders (ASD). These studies suggest that significant alterations in Zn metabolism may be an important nutritional component in the development of ASD. MATERIALS &
METHODS: The idea that prenatal zinc deficiency may be to blame is cursorily challenged. Epidemiological studies show that high-income countries with a low estimated prevalence of inadequate zinc intake report the highest prevalence of ASD. Consistent with other reports indicating a link between air pollution and ASD, it has recently been proposed that use of the herbicide, glyphosate, in agriculture may serve as an instrumental variable in predicting later neurodevelopmental impairment via emissions of the agricultural air pollutant, nitrous oxide (N2O).
RESULTS: Work in anesthesiology has demonstrated the neurological effects from subanesthetic doses of N2O, including its inhibition of the alpha 7 nicotinic acetylcholine receptor (α7), a receptor coupled to both central nitric oxide (NO) metabolism and peripheral anti-inflammation.
CONCLUSION: This correspondence explores how the aforementioned nutritional phenotypes found by Sayehmiri et al. in their systematic review may be a compensatory mechanism to counter the effects (namely, α7 inhibition) of air pollutant exposures occurring during the most critical stages of fetal development.

Entities:  

Keywords:  Autism spectrum disorders; Copper; Zinc

Year:  2017        PMID: 28883881      PMCID: PMC5582364     

Source DB:  PubMed          Journal:  Iran J Child Neurol        ISSN: 1735-4668


Introduction

Sayehmiri et al. (1) recently conducted a meta-analysis to explore the relationship between zinc and copper metabolism and autism spectrum disorders (ASD). The authors found that a significant correlation did exist between levels of Zn and Cu and development of ASD and further implying that the suspected nutritional imbalance may have pathogenic role in ASD development. Consistent with the review conducted by Sayehmiri et al. (1), Grabrucker et al. (2) published a full behavioral profile of mice exposed to prenatal zinc deficiency and presented a phenotype similar to that found in autism spectrum disorders (ASD), reporting increasing anxiety, alterations in nesting and social behaviors, and impaired communication and motor learning. These studies suggest that significant alterations in Zn metabolism can be considered an important nutritional component in the development of ASD. The idea that prenatal zinc deficiency may be to blame is cursorily challenged, however. Epidemiological studies that show that high-income countries with a low estimated prevalence of inadequate zinc intake (3) report the highest prevalence of ASD (4). Furthermore, the idea of maternal nutrient deficiencies conflicts with the elevation of some minerals like Cu in ASD (5). Therefore, it is important to consider that imbalances of trace minerals in ASD may not reflect fetal micronutrient deficiencies resulting from maternal inflammation; rather, these mineral deficiencies may be a complex, compensatory mechanism brought about to counter gestational environmental exposures. Consistent with a current line of evidence implicating air pollution - and specifically environmental exposure to the agricultural and combustion pollutant, nitrous oxide (N2O), - as a risk factor in ASD (6,7), it has been previously suggested that N2O-mediated inhibition of the human alpha-7 nicotinic acetylcholine receptor (α7) (8), a ligand-gated ion channel highly permeable to Ca2+ ions which is coupled to neuronal nitric oxide synthase (nNOS) activity (9,10) and implicated in both attention (11) and anti-inflammation (12), would lead to a critical nNOS uncoupling. (7,13). Ex-vivo analysis on cultured brains indicates that neuronally generated NO may stimulate axon pruning yet inhibit neuron regrowth (14), suggesting that the uncoupling of central NO metabolism may contribute to defective pruning found in autism (15). Not only would this central nNOS disruption lead to ADHD symptoms in ASD (16) but profound metabolic changes would also occur, mediated in part by abnormal oxidative stress markers shunted into the periphery in a compensatory exercise to restore central nitric oxide (NO) metabolism (13). Peripheral mechanisms, including altered Zn status in ASD, may follow as a compensatory cascade to re-establish dysregulated central NO metabolism. This argument is supported with the evidence that serum NO levels were found to be significantly higher in ASD than aged and gender-matched controls (17). In addition to its role as a blocker of wild-type α7 (18), Cortese-Krott et al. (19) demonstrated using a series of luciferase reporter assays that zinc potently regulates NO output in aortic endothelial cells through its inhibition of the NF-kB-dependent transactivation of the inducible nitric oxide synthase (iNOS) promoter. Cui et al. (20) previously reported that zinc deficiency promoted the induction of IL-1A-mediated iNOS activity in rat intestine, and this effect was rapidly reversed with zinc repletion. Lung injury in adult male rats fed a zinc-deficient diet was characterized by pulmonary edema, lung NO production, higher expression of iNOS and other biomarkers indicative of NF-kappaB activation (21). These anatomic-specific antagonistic relationships are undergirded by the role that Zn plays in NOS dimer stability, which may be mediated by intimate communication between the Zn and tetrahydrobiopterin (BH4) binding sites (22). Since iNOS is the least stable isozyme of the three (23), reduced serum Zn may reflect the role of iNOS in peripheral redox environments (24) such as that imposed from a N2O-mediated impairment in central NO metabolism. Whereas Zn possesses anti-inflammatory action in human health (25), Cu exerts a pro-inflammatory effect via substantial upregulation in iNOS activity similar to the inflammatory cascade induced by bacterial LPS (26). Demura et al. (27) clarified that Cu-induced activation of endothelial NOS in human pulmonary arterial endothelial cells was dose-dependent and occurred in the presence of extracellular Ca2+. In isolated rat aortic rings precontracted with phenylephrine, administration of a Cu2+ chelator (diethyldithiocarbamic acid) inhibited smooth muscle relaxation induced by 100 uM sodium nitroprusside (SNP), a NO donor, which was reversed by equimolar concentration of Cu2+ but not Fe2+, suggesting Cu2+ is necessary in SNP-evoked smooth muscle relaxation (28). These data suggest that the altered Zn/Cu ratio in ASD reported by Sayehmiri et al. (1) may have functional significance insofar as subsidizing the physiological restoration of impaired central NO metabolism due to chronic, gestational exposure to air pollutants, like N2O. These data argue that Zn deficiencies and Cu excess in ASD may not simply reflect a state of nutritional deficiencies attributable to maternal inflammation from environmental exposures. In fact, the data presented here argue otherwise: that is, gestational exposures to air pollutants may perturb fetal α7 subunit, a receptor that is coupled to central NO metabolism and has been shown to counter peripheral inflammation. Fetal dysregulation of this factor, perhaps among many other known N2O targets, may indirectly potentiate an oxidative stress burden and a fetal inflammatory overload (as characterized by the nutrient profiles herein described) in a vital attempt to overcome dysfunctional central NO metabolism. It is, therefore, critical to thoroughly consider that these nutritional phenotypes may be a purposeful compensatory mechanism (and not just a consequence) to counter air pollutant exposures occurring during the most critical stages of fetal development. Toxicological studies assessing chronic N2O exposure should be undertaken to better understand these potential dynamics herein described. Ethical approval: This article does not contain any studies with human participants or animals performed by any of the authors.

Author’s Contributions

KF contributed solely to the content of this correspondence.

Conflict of Interest:

The author declares no conflict of interest.
  27 in total

1.  Nicotinic-acetylcholine receptors are functionally coupled to the nitric oxide/cGMP-pathway in insect neurons.

Authors:  Ricardo M Zayas; Sanjive Qazi; David B Morton; Barry A Trimmer
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

2.  Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.

Authors:  Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer
Journal:  Neuron       Date:  2014-08-21       Impact factor: 17.173

3.  Nitrous oxide and xenon inhibit the human (alpha 7)5 nicotinic acetylcholine receptor expressed in Xenopus oocyte.

Authors:  Takahiro Suzuki; Kazuyoshi Ueta; Masahiro Sugimoto; Ichiro Uchida; Takashi Mashimo
Journal:  Anesth Analg       Date:  2003-02       Impact factor: 5.108

Review 4.  Does environmental exposure to the greenhouse gas, N2O, contribute to etiological factors in neurodevelopmental disorders? A mini-review of the evidence.

Authors:  Keith Fluegge
Journal:  Environ Toxicol Pharmacol       Date:  2016-08-18       Impact factor: 4.860

5.  High nitric oxide production in autistic disorder: a possible role for interferon-gamma.

Authors:  Thayne L Sweeten; David J Posey; Sudha Shankar; Christopher J McDougle
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

6.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

7.  Plasma copper and zinc concentration in individuals with autism correlate with selected symptom severity.

Authors:  Anthony J Russo; Andrea P Bazin; Richard Bigega; Robert S Carlson; Martin G Cole; Dilenia C Contreras; Matthew B Galvin; Sayde S Gaydorus; Sierra D Holik; Gavin P Jenkins; Brandon M Jones; Penelope A Languell; Padraic J Lyman; Kareem P March; Katie A Meuer; Serena R Peterson; Matthew T Piedmonte; Michael G Quinn; Nicole C Smaranda; Patrick L Steves; Heather P Taylor; Teagan E Waddingham; Janine S Warren
Journal:  Nutr Metab Insights       Date:  2012-02-28

Review 8.  Global prevalence of autism and other pervasive developmental disorders.

Authors:  Mayada Elsabbagh; Gauri Divan; Yun-Joo Koh; Young Shin Kim; Shuaib Kauchali; Carlos Marcín; Cecilia Montiel-Nava; Vikram Patel; Cristiane S Paula; Chongying Wang; Mohammad Taghi Yasamy; Eric Fombonne
Journal:  Autism Res       Date:  2012-04-11       Impact factor: 5.216

9.  Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting.

Authors:  K Ryan Wessells; Kenneth H Brown
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

10.  A reply to 'Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study'.

Authors:  K Fluegge
Journal:  Transl Psychiatry       Date:  2016-04-26       Impact factor: 6.222

View more
  3 in total

Review 1.  Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives.

Authors:  Mehran Shayganfard
Journal:  Biol Trace Elem Res       Date:  2021-04-27       Impact factor: 3.738

Review 2.  Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder.

Authors:  Sang Hoon Yoon; Joonhyuk Choi; Won Ji Lee; Jeong Tae Do
Journal:  J Clin Med       Date:  2020-03-31       Impact factor: 4.241

3.  Zinc and Copper Brain Levels and Expression of Neurotransmitter Receptors in Two Rat ASD Models.

Authors:  Elzbieta Zieminska; Anna Ruszczynska; Justyna Augustyniak; Beata Toczylowska; Jerzy W Lazarewicz
Journal:  Front Mol Neurosci       Date:  2021-06-29       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.